BHC
Bausch Health Companies Inc
NYSE: BHC · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$5.59
-1.41% today
Updated 2026-04-29
Market cap
$2.09B
P/E ratio
13.31
P/S ratio
0.20x
EPS (TTM)
$0.42
Dividend yield
—
52W range
$4 – $9
Volume
1.9M
Bausch Health Companies Inc (BHC) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$5.59
12-Month target
$5.67
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $8.4B | $8.1B | $8.8B | $9.6B | $10.3B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 13.31x (capped 25x) · Margin: 1.53%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.